3 results
Approved WMOPending
To investigate the long-term safety, tolerability and acceptability of Nasalfent in the treatment BTCP
Approved WMOPending
To evaluate the value of a TAP-block for the reduction of postoperative bladder spasm after RALP for prostate cancer
Approved WMOCompleted
To assess the impact of six IV infusions of 3, 6, or 12 mg/kg of CER-001 or placebo, given at weekly intervals, on atherosclerotic plaque volume, as measured by coronary IVUS.